Our History

2014

The company was established with the name Altermune Limited.

2015

Laboratories at Discovery Park, Kent were established and the name change adopted. Staff numbers soon grew to fifteen and research using Alphamer technology was facilitated.

2016

Centauri went on to establish a joint venture company, Avvinity Therapeutics, with Horizon Discovery to undertake oncology research using the Alphamer technology.

2018

Centauri was awarded an Innovate UK grant for £1.3m to undertake anti-infectives research using the Alphamer technology

2019

Centauri was awarded a CARB-X grant for $1.4m to undertake anti-infectives research using the Alphamer technology

2022

Centauri moved its laboratory to Alderley Park, Cheshire and has been awarded a second CARB-X grant for $2.7m to undertake anti-infectives research using the Alphamer technology.